These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 22336225)
1. Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent. Lau AH; Lai HK; Yeung BH; Leung SL; Tsang SY; Wong YH; Wise H Prostaglandins Leukot Essent Fatty Acids; 2012 Mar; 86(3):119-26. PubMed ID: 22336225 [TBL] [Abstract][Full Text] [Related]
2. Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling. Lo RK; Liu AM; Wise H; Wong YH Cell Signal; 2008 Nov; 20(11):2095-106. PubMed ID: 18755267 [TBL] [Abstract][Full Text] [Related]
3. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK. Lo RK; Wise H; Wong YH Cell Signal; 2006 Mar; 18(3):307-17. PubMed ID: 15979846 [TBL] [Abstract][Full Text] [Related]
4. The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells. Shen HW; Chen YL; Chern CY; Kan WM Prostaglandins Other Lipid Mediat; 2007 May; 83(3):231-6. PubMed ID: 17481561 [TBL] [Abstract][Full Text] [Related]
5. RAD001-mediated STAT3 upregulation and megakaryocytic differentiation. Su YC; Li SC; Peng HY; Ho YH; Chen LJ; Liao HF Thromb Haemost; 2013 Mar; 109(3):540-9. PubMed ID: 23329056 [TBL] [Abstract][Full Text] [Related]
6. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells. Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554 [TBL] [Abstract][Full Text] [Related]
7. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins. Schwaner I; Seifert R; Schultz G Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455 [TBL] [Abstract][Full Text] [Related]
8. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells. Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294 [TBL] [Abstract][Full Text] [Related]
9. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate. Schick BP; Thornton RD Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells. Dai W; Murphy MJ Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382 [TBL] [Abstract][Full Text] [Related]
11. CDDO-Im is a stimulator of megakaryocytic differentiation. Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854 [TBL] [Abstract][Full Text] [Related]
12. Staurosporine induces megakaryocytic differentiation through the upregulation of JAK/Stat3 signaling pathway. Peng HY; Liao HF Ann Hematol; 2011 Sep; 90(9):1017-29. PubMed ID: 21331591 [TBL] [Abstract][Full Text] [Related]
13. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells. Cailleteau C; Liagre B; Battu S; Jayat-Vignoles C; Beneytout JL Anal Biochem; 2008 Sep; 380(1):26-34. PubMed ID: 18549804 [TBL] [Abstract][Full Text] [Related]
14. Adherence of human erythroleukemia cells inhibits proliferation without inducing differentiation. Molla A; Block MR Cell Growth Differ; 2000 Feb; 11(2):83-90. PubMed ID: 10714764 [TBL] [Abstract][Full Text] [Related]
15. A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons. Nakae K; Saito K; Iino T; Yamamoto N; Wakabayashi M; Yoshikawa S; Matsushima S; Miyashita H; Sugimoto H; Kiba A; Gupta J J Pharmacol Exp Ther; 2005 Dec; 315(3):1136-42. PubMed ID: 16109742 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the human prostacyclin receptor gene in megakaryocytes: major roles for C/EBPδ and PU.1. Keating GL; Turner EC; Kinsella BT Biochim Biophys Acta; 2012 May; 1819(5):428-45. PubMed ID: 22381139 [TBL] [Abstract][Full Text] [Related]
17. Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3. Harada Y; Ishii I; Hatake K; Kasahara T Cancer Lett; 2012 Jun; 319(1):83-8. PubMed ID: 22210382 [TBL] [Abstract][Full Text] [Related]
18. Changes in protein sulfation in human erythroleukemia (HEL), CHRF-288-11, and K562 cells following treatment with dimethyl sulfoxide or phorbol 12-myristate 13-acetate. Schick BP; Tang RP; Jacoby JA Arch Biochem Biophys; 1995 Feb; 317(1):191-200. PubMed ID: 7872784 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of human NDR gene in megakaryocytic differentiation of erythroleukemia K562 cells. Liu CC; Chou YL; Ch'ang LY J Biomed Sci; 2004; 11(1):104-16. PubMed ID: 14730214 [TBL] [Abstract][Full Text] [Related]
20. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells. Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]